These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6220307)

  • 1. [Myeloma with hypereosinophilia. Eosinophil reaction following melphalan].
    Ozgüven O; Sebik F; Basci A
    Presse Med; 1983 Mar; 12(11):704. PubMed ID: 6220307
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myeloma, melphalan and acute myelo-monocytic leukemia. Apropos of a case].
    Cywiner-Golenzer C; Adotti F; Marsan C; Quillard A; Henon P; Grimaldi A; Dryll A
    Sem Hop; 1974 Jan; 50(3):207-11. PubMed ID: 4367926
    [No Abstract]   [Full Text] [Related]  

  • 3. Stem cell mobilization in heavily pretreated multiple myeloma patients with prior high dose melphalan and auto-SCT.
    Khaled Y; Al-Hazzouri A; Mizrachi A; Reynolds R; Reddy V; Solh M
    Bone Marrow Transplant; 2013 Feb; 48(2):310-1. PubMed ID: 22773127
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of multiple myeloma terminating with acute myelomonocytic leukemia after long-term melphalan therapy.
    Ota H; Ikeda Y; Shibata T; Hirabayashi N
    Nihon Ketsueki Gakkai Zasshi; 1974 Feb; 37(1):49-57. PubMed ID: 4526861
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in peripheral blood monocyte number in patients with multiple myeloma treated with melphalan].
    Mendek-Czajkowska E; Rostkowska J; Mariańska B; Sawicki Z; Maj S
    Acta Haematol Pol; 1984; 15(3-4):119-24. PubMed ID: 6537120
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythroleukemia following melphalan therapy for multiple myeloma.
    Fishman SA; Ritz ND
    N Y State J Med; 1975 Nov; 75(13):2402-4. PubMed ID: 1059018
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute hemolysis caused by glucose-6-phosphate dehydrogenase deficiency at the outset of myeloma therapy. Role of melphalan?].
    Casassus P; Vannetzel JM; Lortholary P
    Nouv Presse Med; 1982 Jun; 11(30):2296. PubMed ID: 7110993
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multiple myeloma preceding myelodysplastic syndrome with eosinophilia and der (1;7)].
    Matano S; Kobayashi K; Nakamura S; Yoshida T
    Rinsho Ketsueki; 1994 Nov; 35(11):1310-4. PubMed ID: 7823398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of intravenous melphalan in patients with multiple myeloma.
    Brox L; Birkett L; Belch A
    Cancer Treat Rev; 1979 Jun; 6 Suppl():27-32. PubMed ID: 498169
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myelofibrosis following a hyposecreting myeloma treated by vincristine, melphalan].
    Schneider M; Cassuto JP; Duplay H; Viguier E; Lesbats G
    Nouv Presse Med; 1979 Sep; 8(35):2831-2. PubMed ID: 503814
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary fibrosis following therapy with Melphalan for multiple myeloma.
    Codling BW; Chakera TM
    J Clin Pathol; 1972 Aug; 25(8):668-73. PubMed ID: 5076801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myeloma and myelomonocytic leukemia. Role of melphalan. Ultrastructural and cytoenzymologic study].
    Marsan C; Henon P; Quillard A; Grimaldi A; Cywiner-Golenzer C; Adotti F; Dryll A; Roujeau J
    Pathol Eur; 1973; 8(4):287-98. PubMed ID: 4523953
    [No Abstract]   [Full Text] [Related]  

  • 13. [Case of IgG-K myeloma successfully treated with melphalan but terminating in acute myelogenous leukemia 2 years and 8 months later].
    Saitoh A; Tsushima T; Narita K; Fujiwara S; Kawamura S; Chiba Y; Yoshida Y
    Rinsho Ketsueki; 1982 Jun; 23(6):862-9. PubMed ID: 6960198
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gynecomastia appearing during myeloma: role of melphalan?].
    Cohen JD; Fulpin J; Chouc PY; Jeandel P
    Presse Med; 2000 Nov; 29(35):1936. PubMed ID: 11244624
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypersensitivity reactions to iv melphalan during treatment of multiple myeloma: Cancer and Leukemia Group B experience.
    Cornwell GG; Pajak TF; McIntyre OR
    Cancer Treat Rep; 1979 Mar; 63(3):399-403. PubMed ID: 427822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Multiple myeloma, melphalan, and neoplasia.
    Barclay WR
    JAMA; 1976 Oct; 236(14):1612. PubMed ID: 989138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Letter: Myeloma and myelo-monocytic leukemia. Role of melphalan].
    Marsan C; Henon P; Quillard A; Grimaldi A; Cywiner-Golener C
    Nouv Presse Med; 1973 Dec; 2(44):2958. PubMed ID: 4521337
    [No Abstract]   [Full Text] [Related]  

  • 18. Three cases of multiple myeloma developing into melphalan-related chronic myelomonocytic leukemia.
    Ueki K; Sato S; Tamura J; Sawamura M; Murakami H; Naruse T; Tsuchiya J
    J Med; 1991; 22(3):157-61. PubMed ID: 1770323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple myeloma transforming into acute leukaemia (author's transl)].
    Mayans J; Redon J; Badia L; Herranz C; Calabuig JR; Sanz MA; Soler A; Caballero M; Marty ML
    Sangre (Barc); 1977; 22(6):1026-9. PubMed ID: 601670
    [No Abstract]   [Full Text] [Related]  

  • 20. [Development of acute leukosis in multiple myeloma after prolonged treatment with melphalan].
    Scheinberg MA; Bezerra JB; Silveira LA; Ferreira HC; Maspes V
    AMB Rev Assoc Med Bras; 1978 Oct; 24(10):356-7. PubMed ID: 311053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.